2022
The role of cardiac magnetic resonance-based feature-tracking strain analysis in the differential diagnosis and prognostic assessment of patients with left ventricular hypertrophy
Dohy Z, Szabo L, Pozsonyi Z, Csecs I, Toth A, Suhai F, Czimbalmos C, Szucs A, Kiss A, Becker D, Merkely B, Vago H. The role of cardiac magnetic resonance-based feature-tracking strain analysis in the differential diagnosis and prognostic assessment of patients with left ventricular hypertrophy. European Heart Journal 2022, 43: ehac544.272. DOI: 10.1093/eurheartj/ehac544.272.Peer-Reviewed Original ResearchFeature-tracking strain analysisCardiac magnetic resonanceLeft ventricular hypertrophyLV hypertrophyMyocardial diseaseHypertrophic cardiomyopathyEndomyocardial fibrosisBasal LSCardiac amyloidosisCA patientsVentricular hypertrophyGlobal dyssynchronyDifferential diagnosisLeft ventricular (LV) hypertrophyPatient populationCardiac magnetic resonance examinationLV stroke volume indexFabry diseasePrognostic assessment of patientsSignificant independent predictors of mortalityIndependent predictor of mortalityEndomyocardial fibrosis patientsLV strain parametersLV) hypertrophyLV strain analysisPotential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis
Dohy Z, Szabo L, Pozsonyi Z, Csecs I, Toth A, Suhai F, Czimbalmos C, Szucs A, Kiss A, Becker D, Merkely B, Vago H. Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis. PLOS ONE 2022, 17: e0269807. PMID: 35696411, PMCID: PMC9191721, DOI: 10.1371/journal.pone.0269807.Peer-Reviewed Original ResearchConceptsCardiac AL amyloidosisCardiac magnetic resonanceLate gadolinium enhancementAL amyloidosisOptimal diagnostic performanceHypertrophic cardiomyopathyDegree of left ventricular (LV) hypertrophyReduced global LV longitudinal strainDiagnostic performanceLeft ventricular (LV) hypertrophyPattern of late gadolinium enhancementGlobal LV longitudinal strainSubendocardial late gadolinium enhancementCardiac magnetic resonance examinationCardiac magnetic resonance parametersCardiac light-chain amyloidosisDifferential diagnosis of cardiomyopathyLV strain parametersCardiac transthyretin amyloidosisLV) hypertrophyLV longitudinal strainDiagnosis of cardiomyopathyLight chain amyloidosisCardiac light chainsPotential clinical relevance
2021
The role of feature-tracking strain analysis in the differentiation of cardiac amyloidosis from hypertrophic cardiomyopathy
Dohy Z, Szabo L, Pozsonyi Z, Csecs I, Toth A, Suhai F, Czimbalmos C, Szucs A, Kiss A, Becker D, Merkely B, Vago H. The role of feature-tracking strain analysis in the differentiation of cardiac amyloidosis from hypertrophic cardiomyopathy. European Heart Journal 2021, 42: ehab724.0240. DOI: 10.1093/eurheartj/ehab724.0240.Peer-Reviewed Original ResearchCardiac involvement of amyloidosisLeft ventricular ejection fractionLate gadolinium enhancementCardiac magnetic resonanceAmount of late gadolinium enhancementHypertrophic cardiomyopathy patientsFeature-tracking strain analysisCA patientsHypertrophic cardiomyopathyBasal LSDiagnostic accuracyPattern of late gadolinium enhancementCardiac magnetic resonance diagnosisCardiac magnetic resonance examinationSignificant independent predictors of mortalityCox proportional hazards regression analysisIndependent predictor of mortalityLV strain parametersRegional strain valuesYears of follow-upProportional hazards regression analysisVentricular ejection fractionOptimal cutoff valueLog-rank testDiagnosis of CA
2020
Cardiac changes after cardiac resynchronization therapy assessed using cardiac magnetic resonance imaging during biventricular pacing
Czimbalmos C, Papp R, Szabo L, Toth A, Csecs I, Suhai F, Molnar L, Kosztin A, Geller L, Merkely B, Vago H. Cardiac changes after cardiac resynchronization therapy assessed using cardiac magnetic resonance imaging during biventricular pacing. European Heart Journal 2020, 41: ehaa946.0808. DOI: 10.1093/ehjci/ehaa946.0808.Peer-Reviewed Original ResearchCardiac magnetic resonanceCardiac resynchronization therapyCardiac magnetic resonance imagingBiventricular pacingRegional dyssynchronyResynchronization therapyAOO pacingCMR parametersEffectiveness of resynchronization therapyCardiac magnetic resonance examinationEffects of cardiac resynchronization therapyRight ventricular ejection fractionEnd-systolic volume indexQuantification of LV functionRemodeling indexConventional CMR parametersImprove responder rateLV remodeling indexII-III patientsOptimal medical therapyRight ventricular volumesVentricular ejection fractionEnd-diastolic indexEffects of cardiac resynchronizationRelative wall thickness
2019
Biventricular pacing during cardiac magnetic resonance imaging
Vago H, Czimbalmos C, Papp R, Szabo L, Toth A, Dohy Z, Csecs I, Suhai F, Kosztin A, Molnar L, Geller L, Merkely B. Biventricular pacing during cardiac magnetic resonance imaging. EP Europace 2019, 22: 117-124. PMID: 31713632, DOI: 10.1093/europace/euz289.Peer-Reviewed Original ResearchConceptsLV end-systolic volume indexLV ejection fractionLV end-diastolic volume indexNew York Heart AssociationCardiac magnetic resonance imagingCardiac magnetic resonanceRegional dyssynchronyBiventricular pacingAOO pacingMagnetic resonance imagingCMR parametersEffectiveness of resynchronization therapyLeft ventricular remodeling indexLeft ventricular (LV) functionCardiac magnetic resonance examinationEnd-diastolic volume indexEnd-systolic volume indexQuantification of LV functionVolume indexRemodeling indexConventional CMR parametersImprove responder rateResonance imagingOptimal medical therapyEffects of cardiac resynchronization